DEF 14A

Company

Cellectar Biosciences, Inc.

Filed

October 28, 2015

Period of Report

November 30, 2015

Accession Number

0001144204-15-061203

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →